FDA Import Refusal AEK-0113241-3/110002/1 — GLAXOSMITHKLINE PHARMACEUTICALS
The FDA refused shipment AEK-0113241-3/110002/1 from GLAXOSMITHKLINE PHARMACEUTICALS (India) on Mar 30, 2026. The refused product falls under Drugs and Biologics — NEOMYCIN SULFATE (AMINOGLYCOSIDES). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56DDY41 NEOMYCIN SULFATE (AMINOGLYCOSIDES)
- Charges
- 75